4.6 Article

Interleukin 24 promotes cell death in renal epithelial cells and is associated with acute renal injury

期刊

AMERICAN JOURNAL OF TRANSPLANTATION
卷 22, 期 11, 页码 2548-2559

出版社

WILEY
DOI: 10.1111/ajt.17143

关键词

basic (laboratory) research/science; kidney transplantation/nephrology; kidney disease: immune/inflammatory; kidney (allograft) function/dysfunction

资金

  1. Deutsche Forschungsgemeinschaft [CRC 1450 -431460824, KFO 342]
  2. Interdisciplinary Centre for Clinical Research (IZKF), University of Munster

向作者/读者索取更多资源

IL24 plays an important role in renal ischemia-reperfusion injury by inducing apoptosis and endoplasmic reticulum stress in renal tubular epithelial cells. It can serve as a biomarker and a potential therapeutic target in patients with ischemia-induced acute kidney injury.
Ischemia-reperfusion injury is a major cause of acute kidney injury. Many cytokines are involved in the pathogenesis of renal ischemia-reperfusion injury. IL24 is a member of the IL10 family and has gained importance because of its apoptosis-inducing effects in tumor disease besides its immunoregulative function. Littles is known about the role of IL24 in kidney disease. Using a mouse model, we found that IL24 is upregulated in the kidney after renal ischemia-reperfusion injury and that tubular epithelial cells and infiltrating inflammatory cells are the source of IL24. Mice lacking IL24 are protected from renal injury and inflammation. Cell culture studies showed that IL24 induces apoptosis in renal tubular epithelial cells, which is accompanied by an increased endoplasmatic reticulum stress response. Moreover, IL24 induces robust expression of endogenous IL24 in tubular cells, fostering ER-stress and apoptosis. In kidney transplant recipients with delayed graft function and patients at high risk to develop acute kidney injury after cardiac surgery IL24 is upregulated in the kidney and serum. Taken together, IL24 can serve as a biomarker, plays an important mechanistic role involving both extracellular and intracellular targets, and is a promising therapeutic target in patients at risk of or with ischemia-induced acute kidney injury.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据